[Orient Paper, Inc. Announces Unaudited Preliminary Financial Results for Fourth Quarter and Fiscal Year 2016 Company to Host Earnings Conference Call on Thursday, March 23, 2017, at 8:00 am ET Fourth Quarter and Fiscal Year 2016 Selected Financial Highlights (Unaudited and Preliminary) For the Three]
[Orient Paper, Inc. Announces Unaudited Preliminary Financial Results for Fourth Quarter and Fiscal Year 2016 Company to Host Earnings Conference Call on Thursday, March 23, 2017, at 8:00 am ET Fourth Quarter and Fiscal Year 2016 Selected Financial Highlights (Unaudited and Preliminary) For the Three]
[EX-3.1 2 f8k022417ex3i_cleantechsol.htm CERTIFICATE OF CHANGE.] []
[EX-3.1 2 f8k022417ex3i_cleantechsol.htm CERTIFICATE OF CHANGE.] []
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 InvestorRelations@amctheatres.com MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 rnoonan@amctheatres.com AMC Entertainment Holdings, Inc. Announces Record Fourth Quarter and Year-End 2016 Results Transformative 2016 vaults AMC to #1 in the U.S., in Eur]
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 InvestorRelations@amctheatres.com MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 rnoonan@amctheatres.com AMC Entertainment Holdings, Inc. Announces Record Fourth Quarter and Year-End 2016 Results Transformative 2016 vaults AMC to #1 in the U.S., in Eur]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
[FOR RELEASE February 23, 2017 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 -- 4Q16 Total Sales Up 13.6% YoY to $77.6 Million and Net Income Up 19.0% YoY to $19.4 Million in USD terms, or Total Sales Up 21.7% YoY and Non-GAAP Adjusted Net Income Up 40.7% YoY in]
